Geron Corp. (GERN)
1.26
-0.05
(-3.82%)
USD |
NASDAQ |
Dec 08, 16:00
1.26
0.00 (0.00%)
After-Hours: 20:00
Geron Shareholders Equity (Quarterly): 248.71M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cassava Sciences, Inc. | 81.57M |
| SELLAS Life Sciences Group, Inc. | 45.63M |
| GT Biopharma, Inc. | 3.00M |
| Ultragenyx Pharmaceutical, Inc. | 9.159M |
| Arcellx, Inc. | 440.78M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 567.38M |
| Total Liabilities (Quarterly) | 318.68M |
| Debt to Equity Ratio | 1.010 |
| Current Ratio | 5.955 |
| Net Debt Paydown Yield | -3.76% |